Orthofix Medical Inc. (NASDAQ:OFIX) Stake Lessened by AREX Capital Management LP

AREX Capital Management LP cut its holdings in Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 42.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 100,000 shares of the medical device company's stock after selling 74,500 shares during the period. Orthofix Medical makes up approximately 2.5% of AREX Capital Management LP's portfolio, making the stock its 8th biggest position. AREX Capital Management LP owned approximately 0.26% of Orthofix Medical worth $1,746,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. Emerald Mutual Fund Advisers Trust grew its holdings in Orthofix Medical by 35.4% during the fourth quarter. Emerald Mutual Fund Advisers Trust now owns 503,802 shares of the medical device company's stock worth $8,796,000 after buying an additional 131,653 shares in the last quarter. Northern Trust Corp boosted its stake in shares of Orthofix Medical by 8.8% in the 4th quarter. Northern Trust Corp now owns 368,088 shares of the medical device company's stock worth $6,427,000 after buying an additional 29,768 shares during the last quarter. Susquehanna Fundamental Investments LLC purchased a new stake in shares of Orthofix Medical during the fourth quarter valued at approximately $646,000. Price T Rowe Associates Inc. MD raised its stake in shares of Orthofix Medical by 7.4% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 36,425 shares of the medical device company's stock worth $636,000 after purchasing an additional 2,507 shares during the period. Finally, Tower Research Capital LLC TRC grew its position in shares of Orthofix Medical by 120.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 8,458 shares of the medical device company's stock valued at $148,000 after acquiring an additional 4,627 shares during the period. 89.76% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Orthofix Medical

In other news, insider Jorge Andres Cedron sold 3,816 shares of the business's stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $13.31, for a total value of $50,790.96. Following the sale, the insider now directly owns 42,500 shares of the company's stock, valued at $565,675. The trade was a 8.24 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Lucas Vitale sold 4,287 shares of the stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $16.60, for a total transaction of $71,164.20. Following the sale, the insider now directly owns 135,317 shares in the company, valued at $2,246,262.20. This trade represents a 3.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 8,475 shares of company stock valued at $128,065. 2.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Roth Mkm reiterated a "buy" rating and issued a $22.00 price objective on shares of Orthofix Medical in a research note on Wednesday, February 26th. StockNews.com lowered Orthofix Medical from a "buy" rating to a "hold" rating in a report on Wednesday. Finally, Canaccord Genuity Group reaffirmed a "buy" rating and set a $24.00 price objective on shares of Orthofix Medical in a report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, Orthofix Medical currently has an average rating of "Moderate Buy" and a consensus price target of $23.33.

Orthofix Medical Trading Up 4.7 %

Orthofix Medical stock traded up $0.57 during mid-day trading on Thursday, reaching $12.59. 188,844 shares of the company traded hands, compared to its average volume of 259,570. The firm's 50 day moving average price is $15.06 and its 200 day moving average price is $16.96. Orthofix Medical Inc. has a 52-week low of $10.50 and a 52-week high of $20.73. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.39 and a quick ratio of 1.11. The firm has a market capitalization of $491.29 million, a price-to-earnings ratio of -4.02 and a beta of 0.87.

Orthofix Medical Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.